Literature DB >> 10754941

Factors associated with the time elapsed between the initial detection of HIV-1 antibodies and a diagnosis of AIDS among patients followed in Lyons University Hospitals. CISIH Collaborators.

P Vanhems1, D Baratin, R Allard, E Marceillac, F Biron, L Cotte, T Saint-Marc.   

Abstract

OBJECTIVE: To identify the factors associated with a short period between the initial detection of HIV-1 antibodies and AIDS diagnosis among patients from Lyons, France. DESIGN AND
METHOD: Prospective hospital based cohort study of patients diagnosed with AIDS in Lyons University Hospitals from 1994 to 1997. Cox regression was used to identify the variables independently associated with a short period between the first positive HIV-1 detection test and AIDS.
RESULTS: 466 patients were studied, the mean period between the detection of HIV-1 antibodies and AIDS was 48 months and did not change across calendar years. Age < 46 years (hazard ratio (HR) 0.77, 95% confidence interval (CI) 0.58-1.00), HIV-1 transmission by heterosexual contact (HR 1.93, 95% CI 1.49-2.51), Pneumocystis carinii pneumonia (HR 1.67, 95% CI 1.28-2.17), or Kaposi's sarcoma (HR 1.42, 95% CI 1.06-1.90) as the first AIDS defining event, and CD4+ count < 100 x 10(3)/ml (HR 1.25, 95% CI 1.02-1.55) were associated with a short time interval between detection of HIV-1 antibodies and AIDS.
CONCLUSION: Educational interventions focused on heterosexuals and those aged over 45 are needed to promote the early detection of HIV infection, in the hope of reducing transmission and improving individual prognosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10754941      PMCID: PMC1758255          DOI: 10.1136/sti.75.6.389

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  8 in total

1.  Recent dramatic decrease in AIDS cases and HIV-related deaths contrasts with stable rate of new HIV-positive patients detected in Lyon, France, from 1988 to 1997.

Authors:  P Vanhems; D Baratin; C Trépo; D Peyramond; J L Touraine; E Marceillac; J Fabry
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1999-03-01

2.  Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. Tuscany AIDS Study Group.

Authors:  P Pezzotti; P A Napoli; S Acciai; S Boros; R Urciuoli; V Lazzeri; G Rezza
Journal:  AIDS       Date:  1999-02-04       Impact factor: 4.177

3.  Trillion virion delay: time from testing positive for HIV to presentation for primary care.

Authors:  J H Samet; K A Freedberg; M D Stein; R Lewis; J Savetsky; L Sullivan; S M Levenson; R Hingson
Journal:  Arch Intern Med       Date:  1998-04-13

Review 4.  Antiretroviral therapy for HIV infection: promises and problems.

Authors:  P A Volberding; S G Deeks
Journal:  JAMA       Date:  1998-05-06       Impact factor: 56.272

5.  Factors associated with the CD4+ lymphocyte count at diagnosis of acquired immunodeficiency syndrome. The AIDS IN EUROPE Study Group.

Authors:  A N Phillips; A Lazzarin; J Gonzales-Lahoz; N Clumeck; M P Glauser; R Proenca; D Banhegyi; C Pedersen; J D Lundgren; A M Johnson
Journal:  J Clin Epidemiol       Date:  1996-11       Impact factor: 6.437

6.  A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia.

Authors:  B Hirschel; A Lazzarin; P Chopard; M Opravil; H J Furrer; S Rüttimann; P Vernazza; J P Chave; F Ancarani; V Gabriel
Journal:  N Engl J Med       Date:  1991-04-18       Impact factor: 91.245

7.  HIV positive patients first presenting with an AIDS defining illness: characteristics and survival.

Authors:  M C Poznansky; R Coker; C Skinner; A Hill; S Bailey; L Whitaker; A Renton; J Weber
Journal:  BMJ       Date:  1995-07-15

8.  Factors associated with lack of awareness of HIV infection before diagnosis of AIDS.

Authors:  K Porter; P G Wall; B G Evans
Journal:  BMJ       Date:  1993-07-03
  8 in total
  1 in total

1.  Circumstances at HIV diagnosis and progression of disease in older HIV-infected Americans.

Authors:  D S Zingmond; N S Wenger; S Crystal; G F Joyce; H Liu; U Sambamoorthi; L A Lillard; A A Leibowitz; M F Shapiro; S A Bozzette
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.